Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
AACR: Pazdur bemoans state of FDA, warns of political influence
Asked by Fierce if he'd consider returning to the FDA, Pazdur said he wouldn't serve again under the Trump administration "for obvious reasons."
Darren Incorvaia
Apr 18, 2026 4:00am
Trump orders FDA to fast-track reviews of psychedelic drugs
Apr 20, 2026 5:30am
How WuXi AppTec’s Integrated Platform Is Helping Therapies Move Faster from Discovery to Patients
Brought to you by
WuXi AppTec
AACR: Genentech veteran engineers ‘smart’ cancer drug startup
Apr 19, 2026 6:05pm
FDA celebrates animal testing shift as experts eye road ahead
Apr 19, 2026 6:00pm
AACR: Merck unveils PD-1xVEGF bispecific data in NSCLC
Apr 17, 2026 3:00pm
More News
UCB strikes $1.15B deal for cell therapy biotech Neurona
Apr 17, 2026 1:55pm
Metsera sale architect swings to Structure—Chutes & Ladders
Apr 17, 2026 10:10am
OpenAI launches biotech-specific AI model dubbed GPT-Rosalind
Apr 17, 2026 10:00am
Roivant’s CEO thinks China is a ‘red herring’
Apr 17, 2026 8:35am
See more stories